CONMED Corporation updated third quarter guidance for 2023. For the period, the Company now expects full-year revenue between $1.240 billion and $1.260 billion, compared to its prior guidance of between $1.230 billion and $1.260 billion.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
65.78 USD | +6.27% | -9.44% | -39.93% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-39.93% | 2.03B | |
-2.31% | 187B | |
-3.20% | 106B | |
-5.04% | 66.9B | |
+0.20% | 49.45B | |
+17.29% | 48B | |
+4.06% | 40.84B | |
+2.07% | 26.48B | |
+2.36% | 26.25B | |
+12.96% | 24.62B |
- Stock Market
- Equities
- CNMD Stock
- News CONMED Corporation
- CONMED Corporation Updates Third Quarter Guidance for 2023